Comments
Loading...

Myriad Genetics

MYGNNASDAQ
Logo brought to you by Benzinga Data
$28.29
-0.18-0.63%
At Close: -
$28.29
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Equal-Weight
Highest Price Target1
$35.00
Lowest Price Target1
$20.00
Consensus Price Target1
$27.57

Myriad Genetics (NASDAQ:MYGN) Stock, Analyst Ratings, Price Targets, Forecasts

Myriad Genetics Inc has a consensus price target of $27.57 based on the ratings of 15 analysts. The high is $35 issued by Wells Fargo on August 27, 2024. The low is $20 issued by JP Morgan on August 7, 2024. The 3 most-recent analyst ratings were released by Morgan Stanley, Wells Fargo, and Scotiabank on September 19, 2024, August 27, 2024, and August 13, 2024, respectively. With an average price target of $33.67 between Morgan Stanley, Wells Fargo, and Scotiabank, there's an implied 19.01% upside for Myriad Genetics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
1
May
1
Jun
1
1
1
Aug
1
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.2
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Morgan Stanley
Wells Fargo
Scotiabank
Piper Sandler
TD Cowen

1calculated from analyst ratings

Analyst Ratings for Myriad Genetics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Myriad Genetics (MYGN) stock?

A

The latest price target for Myriad Genetics (NASDAQ:MYGN) was reported by Morgan Stanley on September 19, 2024. The analyst firm set a price target for $32.00 expecting MYGN to rise to within 12 months (a possible 13.11% upside). 17 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Myriad Genetics (MYGN)?

A

The latest analyst rating for Myriad Genetics (NASDAQ:MYGN) was provided by Morgan Stanley, and Myriad Genetics initiated their equal-weight rating.

Q

When was the last upgrade for Myriad Genetics (MYGN)?

A

The last upgrade for Myriad Genetics Inc happened on May 8, 2024 when Leerink Partners raised their price target to $35. Leerink Partners previously had a market perform for Myriad Genetics Inc.

Q

When was the last downgrade for Myriad Genetics (MYGN)?

A

There is no last downgrade for Myriad Genetics.

Q

When is the next analyst rating going to be posted or updated for Myriad Genetics (MYGN)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Myriad Genetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Myriad Genetics was filed on September 19, 2024 so you should expect the next rating to be made available sometime around September 19, 2025.

Q

Is the Analyst Rating Myriad Genetics (MYGN) correct?

A

While ratings are subjective and will change, the latest Myriad Genetics (MYGN) rating was a initiated with a price target of $0.00 to $32.00. The current price Myriad Genetics (MYGN) is trading at is $28.29, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch